These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 7719440

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Trends in enzyme therapy for phenylketonuria.
    Kim W, Erlandsen H, Surendran S, Stevens RC, Gamez A, Michols-Matalon K, Tyring SK, Matalon R.
    Mol Ther; 2004 Aug; 10(2):220-4. PubMed ID: 15294168
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Entrapment of phenylalanine ammonia-lyase in silk fibroin for protection from proteolytic attack.
    Inoue S, Matsunaga Y, Iwane H, Sotomura M, Nose T.
    Biochem Biophys Res Commun; 1986 Nov 26; 141(1):165-70. PubMed ID: 3800993
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Partial rescue of neuropathology in the murine model of PKU following administration of recombinant phenylalanine ammonia lyase (pegvaliase).
    Goldfinger M, Zeile WL, Corado CR, O'Neill CA, Tsuruda LS, Laipis PJ, Cooper JD.
    Mol Genet Metab; 2017 Sep 26; 122(1-2):33-35. PubMed ID: 28506393
    [Abstract] [Full Text] [Related]

  • 27. Phenylalanine ammonia-lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria.
    Bourget L, Chang TM.
    FEBS Lett; 1985 Jan 21; 180(1):5-8. PubMed ID: 4038490
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A new therapy prevents intellectual disability in mouse with phenylketonuria.
    Pascucci T, Rossi L, Colamartino M, Gabucci C, Carducci C, Valzania A, Sasso V, Bigini N, Pierigè F, Viscomi MT, Ventura R, Cabib S, Magnani M, Puglisi-Allegra S, Leuzzi V.
    Mol Genet Metab; 2018 May 21; 124(1):39-49. PubMed ID: 29661557
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS, Yannicelli S, White BD, Medeiros DM.
    Mol Genet Metab; 2004 May 21; 82(1):76-82. PubMed ID: 15110326
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Development of pegylated forms of recombinant Rhodosporidium toruloides phenylalanine ammonia-lyase for the treatment of classical phenylketonuria.
    Gámez A, Sarkissian CN, Wang L, Kim W, Straub M, Patch MG, Chen L, Striepeke S, Fitzpatrick P, Lemontt JF, O'Neill C, Scriver CR, Stevens RC.
    Mol Ther; 2005 Jun 21; 11(6):986-9. PubMed ID: 15922970
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Enzymatic control of phenylalanine intake in phenylketonuria.
    Hoskins JA, Jack G, Wade HE, Peiris RJ, Wright EC, Starr DJ, Stern J.
    Lancet; 1980 Feb 23; 1(8165):392-4. PubMed ID: 6101846
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.